228 related articles for article (PubMed ID: 32003827)
21. MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
Li H; Zhou ZQ; Yang ZR; Tong DN; Guan J; Shi BJ; Nie J; Ding XT; Li B; Zhou GW; Zhang ZY
Hepatology; 2017 Jul; 66(1):136-151. PubMed ID: 28194813
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1.
Dong P; Kaneuchi M; Watari H; Hamada J; Sudo S; Ju J; Sakuragi N
Mol Cancer; 2011 Aug; 10():99. PubMed ID: 21851624
[TBL] [Abstract][Full Text] [Related]
23. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
Wu J; Li H; Shi M; Zhu Y; Ma Y; Zhong Y; Xiong C; Chen H; Peng C
J Exp Clin Cancer Res; 2019 Aug; 38(1):348. PubMed ID: 31399111
[TBL] [Abstract][Full Text] [Related]
24. MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.
Zhang W; Lu Z; Gao Y; Ye L; Song T; Zhang X
Biochem Biophys Res Commun; 2015 May; 460(3):793-8. PubMed ID: 25824049
[TBL] [Abstract][Full Text] [Related]
25. TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma.
Shirai K; Nagae G; Seki M; Kudo Y; Kamio A; Hayashi A; Okabe A; Ota S; Tsutsumi S; Fujita T; Yamamoto S; Nakaki R; Kanki Y; Osawa T; Midorikawa Y; Tateishi K; Ichinose M; Aburatani H
Cancer Sci; 2021 Jul; 112(7):2855-2869. PubMed ID: 33970549
[TBL] [Abstract][Full Text] [Related]
26. Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1.
Li L; Qu YW; Li YP
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2816-2822. PubMed ID: 28682437
[TBL] [Abstract][Full Text] [Related]
27. Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.
Wang Y; Dong L; Liu Y
Cancer Biother Radiopharm; 2019 Oct; 34(8):529-536. PubMed ID: 31424277
[No Abstract] [Full Text] [Related]
28. miR-27a-3p promotes the malignant phenotypes of osteosarcoma by targeting ten-eleven translocation 1.
Liu J; Li M; Liu X; Liu F; Zhu J
Int J Oncol; 2018 Apr; 52(4):1295-1304. PubMed ID: 29484426
[TBL] [Abstract][Full Text] [Related]
29. TET1 suppresses colon cancer proliferation by impairing β-catenin signal pathway.
Guo H; Zhu H; Zhang J; Wan B; Shen Z
J Cell Biochem; 2019 Aug; 120(8):12559-12565. PubMed ID: 30825236
[TBL] [Abstract][Full Text] [Related]
30. Promoter Methylation-mediated Silencing of the MiR-192-5p Promotes Endometrial Cancer Progression by Targeting ALX1.
Ni J; Tian W; Liang S; Wang H; Ren Y
Int J Med Sci; 2021; 18(12):2510-2520. PubMed ID: 34104082
[No Abstract] [Full Text] [Related]
31. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
Chen H; Wang Y; Xue F
Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
[TBL] [Abstract][Full Text] [Related]
32. Ten-eleven translocation protein 1 modulates medulloblastoma progression.
Kim H; Kang Y; Li Y; Chen L; Lin L; Johnson ND; Zhu D; Robinson MH; McSwain L; Barwick BG; Yuan X; Liao X; Zhao J; Zhang Z; Shu Q; Chen J; Allen EG; Kenney AM; Castellino RC; Van Meir EG; Conneely KN; Vertino PM; Jin P; Li J
Genome Biol; 2021 Apr; 22(1):125. PubMed ID: 33926529
[TBL] [Abstract][Full Text] [Related]
33. LncRNA NEAT1 promotes endometrial cancer cell proliferation, migration and invasion by regulating the miR-144-3p/EZH2 axis.
Wang W; Ge L; Xu XJ; Yang T; Yuan Y; Ma XL; Zhang XH
Radiol Oncol; 2019 Nov; 53(4):434-442. PubMed ID: 31747378
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro.
Eismann J; Hirschfeld M; Erbes T; Rücker G; Jäger M; Ritter A; Weiss D; Gitsch G; Mayer S
Oncol Rep; 2017 Aug; 38(2):993-1004. PubMed ID: 28627686
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of differentiation antagonizing non-protein coding RNA exerts anti-tumor effect by up-regulating miR-214 in endometrial carcinoma.
Sun J; Gao S; Lu C
Mol Cell Biochem; 2019 Oct; 460(1-2):9-15. PubMed ID: 31161373
[TBL] [Abstract][Full Text] [Related]
36. miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
Prossomariti A; Piazzi G; D'Angelo L; Miccoli S; Turchetti D; Alquati C; Montagna C; Bazzoli F; Ricciardiello L
Mol Cancer Res; 2018 Dec; 16(12):1965-1976. PubMed ID: 30072583
[TBL] [Abstract][Full Text] [Related]
37. Long Noncoding RNA-ATB Impairs the Function of Tumor Suppressor miR-126-Mediated Signals in Endometrial Cancer for Tumor Growth and Metastasis.
Zheng X; Liu M; Song Y; Feng C
Cancer Biother Radiopharm; 2019 Feb; 34(1):47-55. PubMed ID: 30601064
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-182 promotes tumor cell growth by targeting transcription elongation factor A-like 7 in endometrial carcinoma.
Guo Y; Liao Y; Jia C; Ren J; Wang J; Li T
Cell Physiol Biochem; 2013; 32(3):581-90. PubMed ID: 24021963
[TBL] [Abstract][Full Text] [Related]
39. Multiple Functions of Ten-eleven Translocation 1 during Tumorigenesis.
Tian YP; Zhu YM; Sun XH; Lai MD
Chin Med J (Engl); 2016 Jul; 129(14):1744-51. PubMed ID: 27411465
[TBL] [Abstract][Full Text] [Related]
40. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells.
Lu M; Ding N; Zhuang S; Li Y
Mol Cell Biochem; 2020 Jun; 469(1-2):9-19. PubMed ID: 32314193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]